Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

COMT genotype affects prefrontal white matter pathways in children and adolescents.

Thomason ME, Dougherty RF, Colich NL, Perry LM, Rykhlevskaia EI, Louro HM, Hallmayer JF, Waugh CE, Bammer R, Glover GH, Gotlib IH.

Neuroimage. 2010 Nov 15;53(3):926-34. doi: 10.1016/j.neuroimage.2010.01.033. Epub 2010 Jan 18.

2.

COMT genotype affects brain white matter pathways in attention-deficit/hyperactivity disorder.

Hong SB, Zalesky A, Park S, Yang YH, Park MH, Kim B, Song IC, Sohn CH, Shin MS, Kim BN, Cho SC, Kim JW.

Hum Brain Mapp. 2015 Jan;36(1):367-77. doi: 10.1002/hbm.22634. Epub 2014 Sep 9.

PMID:
25201318
3.

Haplotypes of catechol-O-methyltransferase modulate intelligence-related brain white matter integrity.

Liu B, Li J, Yu C, Li Y, Liu Y, Song M, Fan M, Li K, Jiang T.

Neuroimage. 2010 Mar;50(1):243-9. doi: 10.1016/j.neuroimage.2009.12.020. Epub 2009 Dec 11.

PMID:
20005296
4.

Prefrontal white matter impairment in substance users depends upon the catechol-o-methyl transferase (COMT) val158met polymorphism.

Zhang X, Lee MR, Salmeron BJ, Stein DJ, Hong LE, Geng X, Ross TJ, Li N, Hodgkinson C, Shen PH, Yang Y, Goldman D, Stein EA.

Neuroimage. 2013 Apr 1;69:62-9. doi: 10.1016/j.neuroimage.2012.11.056. Epub 2012 Dec 6.

PMID:
23219927
5.

Magnified effects of the COMT gene on white-matter microstructure in very old age.

Papenberg G, Lövdén M, Laukka EJ, Kalpouzos G, Keller L, Graff C, Köhncke Y, Li TQ, Fratiglioni L, Bäckman L.

Brain Struct Funct. 2015 Sep;220(5):2927-38. doi: 10.1007/s00429-014-0835-4. Epub 2014 Jul 24.

PMID:
25056932
6.

The COMT val158met polymorphism and brain morphometry in healthy young adults.

Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D.

Neurosci Lett. 2006 Sep 11;405(1-2):34-9. Epub 2006 Jul 18.

PMID:
16857316
7.

Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.

Lo Bianco L, Blasi G, Taurisano P, Di Giorgio A, Ferrante F, Ursini G, Fazio L, Gelao B, Romano R, Papazacharias A, Caforio G, Sinibaldi L, Popolizio T, Bellantuono C, Bertolino A.

Psychol Med. 2013 Feb;43(2):279-92. doi: 10.1017/S0033291712001134. Epub 2012 May 23.

PMID:
22617427
8.

Oppositional COMT Val158Met effects on resting state functional connectivity in adolescents and adults.

Meyer BM, Huemer J, Rabl U, Boubela RN, Kalcher K, Berger A, Banaschewski T, Barker G, Bokde A, Büchel C, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Ittermann B, Jia T, Lathrop M, Martinot JL, Nees F, Rietschel M, Smolka MN, Bartova L, Popovic A, Scharinger C, Sitte HH, Steiner H, Friedrich MH, Kasper S, Perkmann T, Praschak-Rieder N, Haslacher H, Esterbauer H, Moser E, Schumann G, Pezawas L.

Brain Struct Funct. 2016 Jan;221(1):103-14. doi: 10.1007/s00429-014-0895-5. Epub 2014 Oct 16.

9.

The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder.

Kim B, Yoo E, Lee JY, Lee KS, Choe AY, Lee JE, Kwack K, Yook KH, Choi TK, Lee SH.

J Affect Disord. 2013 May;147(1-3):64-71. doi: 10.1016/j.jad.2012.10.009. Epub 2012 Nov 7.

PMID:
23141115
10.

COMT Val158Met genotype influences neurodegeneration within dopamine-innervated brain structures.

Gennatas ED, Cholfin JA, Zhou J, Crawford RK, Sasaki DA, Karydas A, Boxer AL, Bonasera SJ, Rankin KP, Gorno-Tempini ML, Rosen HJ, Kramer JH, Weiner M, Miller BL, Seeley WW.

Neurology. 2012 May 22;78(21):1663-9. doi: 10.1212/WNL.0b013e3182574fa1. Epub 2012 May 9.

11.

The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.

Bellgrove MA, Domschke K, Hawi Z, Kirley A, Mullins C, Robertson IH, Gill M.

Exp Brain Res. 2005 Jun;163(3):352-60. Epub 2005 Jan 15.

PMID:
15654584
12.

Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains.

Du L, Merali Z, Poulter MO, Palkovits M, Faludi G, Anisman H.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 3;50:178-83. doi: 10.1016/j.pnpbp.2013.12.016. Epub 2014 Jan 2.

PMID:
24389396
13.

Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume.

Cerasa A, Gioia MC, Labate A, Liguori M, Lanza P, Quattrone A.

Neuroreport. 2008 Mar 5;19(4):405-8. doi: 10.1097/WNR.0b013e3282f5f784.

PMID:
18287936
14.
15.

Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation.

Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR.

Arch Gen Psychiatry. 2006 Dec;63(12):1396-406.

PMID:
17146014
16.

Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.

Giakoumaki SG, Roussos P, Bitsios P.

Neuropsychopharmacology. 2008 Dec;33(13):3058-68. doi: 10.1038/npp.2008.82. Epub 2008 Jun 4.

17.

Catechol-O-methyltransferase (COMT) val158met genotype is associated with BOLD response as a function of task characteristic.

Ettinger U, Kumari V, Collier DA, Powell J, Luzi S, Michel TM, Zedomi O, Williams SC.

Neuropsychopharmacology. 2008 Dec;33(13):3046-57. doi: 10.1038/sj.npp.1301658. Epub 2008 Jan 30.

18.

Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.

McIntosh AM, Baig BJ, Hall J, Job D, Whalley HC, Lymer GK, Moorhead TW, Owens DG, Miller P, Porteous D, Lawrie SM, Johnstone EC.

Biol Psychiatry. 2007 May 15;61(10):1127-34. Epub 2006 Oct 2.

PMID:
17014827
19.

Dopamine effects on human error processing depend on catechol-O-methyltransferase VAL158MET genotype.

Mueller EM, Makeig S, Stemmler G, Hennig J, Wacker J.

J Neurosci. 2011 Nov 2;31(44):15818-25. doi: 10.1523/JNEUROSCI.2103-11.2011.

20.

The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.

Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H.

Brain. 2006 Feb;129(Pt 2):399-410. Epub 2005 Dec 5.

PMID:
16330500

Supplemental Content

Support Center